IMLYGIC is a modified HSV-1 vector encoding the human granulocyte-macrophage colony-stimulating factor (GM-CSF) gene, which has been approved for the treatment of advanced melanoma [80,82]. This evidence concerns the gene CSF2 and melanoma.